432 related articles for article (PubMed ID: 28544305)
1. A practical guide for evaluating gonadal germ cell tumor predisposition in differences of sex development.
Pyle LC; Nathanson KL
Am J Med Genet C Semin Med Genet; 2017 Jun; 175(2):304-314. PubMed ID: 28544305
[TBL] [Abstract][Full Text] [Related]
2. Gonadal tumors in a contemporary cohort of patients with differences in sex development undergoing surgery - A multi-site study from the Pediatric Urologic Oncology Working Group of the societies for pediatric urology.
Peard LM; Morin J; Flores V; Graham K; Taylor AS; Pope JC; Halstead V; Cost NG; Roberts EM; Makari JH; Cranford W; Saltzman AF
J Pediatr Urol; 2023 Aug; 19(4):399.e1-399.e8. PubMed ID: 37117082
[TBL] [Abstract][Full Text] [Related]
3. Patients with disorders of sex development (DSD) at risk of gonadal tumour development: management based on laparoscopic biopsy and molecular diagnosis.
Wünsch L; Holterhus PM; Wessel L; Hiort O
BJU Int; 2012 Dec; 110(11 Pt C):E958-65. PubMed ID: 22540217
[TBL] [Abstract][Full Text] [Related]
4. Tumor risk in disorders of sex development.
Pleskacova J; Hersmus R; Oosterhuis JW; Setyawati BA; Faradz SM; Cools M; Wolffenbuttel KP; Lebl J; Drop SL; Looijenga LH
Sex Dev; 2010 Sep; 4(4-5):259-69. PubMed ID: 20558977
[TBL] [Abstract][Full Text] [Related]
5. Gonadal malignancy risk and prophylactic gonadectomy in disorders of sexual development.
Abacı A; Çatlı G; Berberoğlu M
J Pediatr Endocrinol Metab; 2015 Sep; 28(9-10):1019-27. PubMed ID: 25879315
[TBL] [Abstract][Full Text] [Related]
6. Oncologic outcomes of pre-malignant and invasive germ cell tumors in patients with differences in sex development - A systematic review.
Morin J; Peard L; Vanadurongvan T; Walker J; Dönmez Mİ; Saltzman AF
J Pediatr Urol; 2020 Oct; 16(5):576-582. PubMed ID: 32564942
[TBL] [Abstract][Full Text] [Related]
7. New insights into type II germ cell tumor pathogenesis based on studies of patients with various forms of disorders of sex development (DSD).
Hersmus R; de Leeuw BH; Wolffenbuttel KP; Drop SL; Oosterhuis JW; Cools M; Looijenga LH
Mol Cell Endocrinol; 2008 Sep; 291(1-2):1-10. PubMed ID: 18403106
[TBL] [Abstract][Full Text] [Related]
8. Risk of gonadal neoplasia in patients with disorders/differences of sex development.
Slowikowska-Hilczer J; Szarras-Czapnik M; Duranteau L; Rapp M; Walczak-Jedrzejowska R; Marchlewska K; Oszukowska E; Nordenstrom A;
Cancer Epidemiol; 2020 Dec; 69():101800. PubMed ID: 32905884
[TBL] [Abstract][Full Text] [Related]
9. Differences in gonadal tissue cryopreservation practices for differences of sex development across regions in the United States.
Siebert AL; Gomez-Lobo V; Johnson EK; Nahata L; Orwig KE; Pyle LC; Witchel SF; Finlayson C; Laronda MM
Front Endocrinol (Lausanne); 2022; 13():990359. PubMed ID: 36733807
[TBL] [Abstract][Full Text] [Related]
10. Gonadal development and tumor formation at the crossroads of male and female sex determination.
Cools M; Wolffenbuttel KP; Drop SL; Oosterhuis JW; Looijenga LH
Sex Dev; 2011; 5(4):167-80. PubMed ID: 21791949
[TBL] [Abstract][Full Text] [Related]
11. Gonadal tumour risk in 292 phenotypic female patients with disorders of sex development containing Y chromosome or Y-derived sequence.
Huang H; Wang C; Tian Q
Clin Endocrinol (Oxf); 2017 Apr; 86(4):621-627. PubMed ID: 27862157
[TBL] [Abstract][Full Text] [Related]
12. Disorder of sex development with germ cell tumors: Which is uncovered first?
Faure-Conter C; Orbach D; Fresneau B; Verité C; Bonneau J; Thebaud E; Poirée M; Thouvenin S; Pluchart C; Mure PY; Dijoud F; Morel Y
Pediatr Blood Cancer; 2020 Apr; 67(4):e28169. PubMed ID: 32020769
[TBL] [Abstract][Full Text] [Related]
13. Gonadal Tissue Cryopreservation for Children with Differences of Sex Development.
Johnson EK; Finlayson C; Finney EL; Harris CJ; Tan SY; Laronda MM; Lockart BA; Chen D; Rowell EE; Cheng EY; Yerkes EB
Horm Res Paediatr; 2019; 92(2):84-91. PubMed ID: 31509845
[TBL] [Abstract][Full Text] [Related]
14. Gonadal maldevelopment as risk factor for germ cell cancer: towards a clinical decision model.
van der Zwan YG; Biermann K; Wolffenbuttel KP; Cools M; Looijenga LH
Eur Urol; 2015 Apr; 67(4):692-701. PubMed ID: 25240975
[TBL] [Abstract][Full Text] [Related]
15. Pathogenesis of germ cell neoplasia in testicular dysgenesis and disorders of sex development.
Jørgensen A; Lindhardt Johansen M; Juul A; Skakkebaek NE; Main KM; Rajpert-De Meyts E
Semin Cell Dev Biol; 2015 Sep; 45():124-37. PubMed ID: 26410164
[TBL] [Abstract][Full Text] [Related]
16. Malignancy in disorders of sex development.
Kathrins M; Kolon TF
Transl Androl Urol; 2016 Oct; 5(5):794-798. PubMed ID: 27785439
[TBL] [Abstract][Full Text] [Related]
17. Gonadal tumours and DSD.
Looijenga LH; Hersmus R; de Leeuw BH; Stoop H; Cools M; Oosterhuis JW; Drop SL; Wolffenbuttel KP
Best Pract Res Clin Endocrinol Metab; 2010 Apr; 24(2):291-310. PubMed ID: 20541153
[TBL] [Abstract][Full Text] [Related]
18. Germ cell tumors in the intersex gonad: old paths, new directions, moving frontiers.
Cools M; Drop SL; Wolffenbuttel KP; Oosterhuis JW; Looijenga LH
Endocr Rev; 2006 Aug; 27(5):468-84. PubMed ID: 16735607
[TBL] [Abstract][Full Text] [Related]
19. Malignant Germ Cell Tumors and Their Precursor Gonadal Lesions in Patients with XY-DSD: A Case Series and Review of the Literature.
Steinmacher S; Brucker SY; Kölle A; Krämer B; Schöller D; Rall K
Int J Environ Res Public Health; 2021 May; 18(11):. PubMed ID: 34070473
[TBL] [Abstract][Full Text] [Related]
20. Tumor risk in disorders of sex development (DSD).
Looijenga LH; Hersmus R; Oosterhuis JW; Cools M; Drop SL; Wolffenbuttel KP
Best Pract Res Clin Endocrinol Metab; 2007 Sep; 21(3):480-95. PubMed ID: 17875493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
